All subsidiaries expected to achieve positive Adjusted EBITDA* in fiscal year 2027CPS rebranding and refocusing growth around Celebrity ...

First Quarter Revenue was $647.9 million, a 15.9% increase over the prior year period First Quarter Net income was $41.7 million compared to $5.2 ...

GE Vernova shares jumped 9% after strong Q4FY26 results. Brokerages raised targets on record ₹21,500-crore backlog, exports ...

Q4 2025. Management View “During our 2025 year-end closing process, we identified 3 issues requiring further review related to lease ...

Q1 2026 Earnings Call May 18, 2026 4:00 PM EDTCompany ParticipantsWilliam Li - President, CEO & ChairmanApoorv Dwivedi ...

Management highlighted a multiyear Tier 1 customer renewal, explicitly expanding RADCOM ACE’s AI-driven service assurance ...

Starbucks Corporation SBUX is showing early signs of margin recovery, a fundamental likely to draw investor attention as the ...

Elara estimates the impact could be around ₹100-200 crore, translating into a 4-5% hit to FY27 estimated adjusted EBITDA for ...

Monday, May 18, 2026 at 8:30 a.m. ET. CALL PARTICIPANTS. Chairman and CEO — Sumant Sinha; President and Group CFO — Kailash ...

Solara Active Pharma Sciences Ltd (BOM:541540) reports significant growth in revenue and EBITDA, while addressing challenges in the Ibuprofen segment.

Recent Acquisitions powers the Revenue Growth and Gross Profit. PLEASANTON, Calif., May 14, 2026 /CNW/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a lea ...

Sentral real estate investment trust's (Sentral-REIT) earnings are expected to stay resilient in financial year ending Dec 31, 2026 (FY26), supported by full-year contribution from newly acquired ...